Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Porin Insertion in the Outer Mitochondrial Membrane01:12

Porin Insertion in the Outer Mitochondrial Membrane

Porins are beta-barrel proteins translocated to the mitochondrial outer membrane through the TOM complex into the intermembrane space. Porin precursors bind TIM chaperones within the intermembrane space and are guided to the Sorting and Assembly Machinery complex or SAM complex on the outer mitochondrial membrane.
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...
Fates of Pyruvate01:20

Fates of Pyruvate

Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introducing a standardized assessment of patients' interest in and usage of CAM in routine cancer care: chances and risks from patients' and physicians' point of view.

Journal of cancer research and clinical oncology·2023
Same author

[Abdominal pain and seizure in a 26-year-old student from England].

Der Internist·2021
Same author

[Porphyrias-what is verified?]

Der Internist·2018
Same author

Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

[Early asymptomatic GIST of the stomach].

Deutsche medizinische Wochenschrift (1946)·2012
Same author

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

Endoscopy·2010
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
10:06

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry

Published on: March 24, 2023

[Porphyrias].

U Stölzel1, T Stauch, M O Doss

  • 1Klinik für Innere Medizin II, Porphyrie Zentrum Sachsen, Klinikum Chemnitz gGmbH, Chemnitz, Germany. u.stoelzel@skc.de

Der Internist
|November 25, 2010
PubMed
Summary
This summary is machine-generated.

Porphyrias are metabolic disorders affecting heme biosynthesis, leading to distinct acute and non-acute forms. Diagnosis and treatment vary based on the specific type and accumulated porphyrins, with transplantation as a last resort.

More Related Videos

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
11:54

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

Published on: October 20, 2019

Related Experiment Videos

Last Updated: Jun 6, 2026

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
10:06

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry

Published on: March 24, 2023

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
11:54

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

Published on: October 20, 2019

Area of Science:

  • Biochemistry
  • Genetics
  • Internal Medicine

Context:

  • Porphyrias represent a group of metabolic disorders stemming from disruptions in the heme biosynthesis pathway.
  • These conditions are clinically categorized into acute and non-acute types, each with unique manifestations and underlying biochemical defects.

Purpose:

  • To elucidate the biochemical basis, clinical differentiation, diagnostic criteria, and therapeutic strategies for various porphyria subtypes.
  • To highlight the correlation between enzyme deficiencies in heme biosynthesis and the resulting patterns of porphyrin accumulation.

Summary:

  • Acute hepatic porphyrias involve the overproduction of neurotoxic porphyrin precursors and porphyrins, presenting with diverse symptoms including abdominal, psychiatric, neurological, and cardiovascular issues. Diagnosis typically relies on a tenfold increase in urinary porphobilinogen.
  • Non-acute porphyrias, such as Porphyria cutanea tarda and erythropoietic porphyrias, result in photosensitivity and potential liver damage due to accumulated porphyrins. Treatment strategies are tailored to the specific porphyria type, with options ranging from symptomatic management to light protection and, in severe cases, transplantation.

Impact:

  • Understanding the specific enzyme defects and resulting porphyrin profiles is crucial for accurate diagnosis and effective management of porphyrias.
  • Current therapeutic approaches include symptomatic treatment, administration of glucose and heme arginate for acute forms, and specific interventions for non-acute types, with transplantation reserved for refractory cases.